Balancing efficacy and toxicity of a fibroblast activation protein dependent tetravalent CD40 agonist antibody for cancer therapy

被引：1
|
作者：
Chen, Simeng
Lin, Yuan
Zhou, Xiaoru
Sun, Xing
Yang, Changyong
Liao, Cheng
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2366
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2366
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti-PD-1 antibody and paclitaxel
    Kobayashi, Chiaki
    Suzuki-Imaizumi, Minami
    Sakaguchi, Yasuko
    Ishii, Toshihiko
    Adachi, Maiko
    Kaneda, Ayumi
    Ebihara, Ritsuko
    Saito, Masato
    Uemori, Takeshi
    Mori, Kiyotoshi
    CANCER SCIENCE, 2024, 115 (12) : 4008 - 4020
  • [22] Fibroblast activation protein (FAP)-CD40 (RO7300490) mediates intratumoral DC maturation and modulation of the tumor microenvironment
    Melero, I.
    Reis, B.
    Lostes Bardaji, M. J.
    Spanggaard, I.
    Lee, D. H.
    Spicer, J.
    Thistlethwaite, F.
    Symeonides, S. N.
    Oh, D-Y.
    Hollebecque, A.
    Rieder, N.
    Schwalie, P.
    Badillo, S.
    Kumpesa, N.
    Thommen, A.
    Rusterholz, C.
    Cirovic, O.
    Kazantzidis, G.
    Garcia, V. Moreno
    Epp, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S279 - S280
  • [23] A phase I study of CD40 agonist monoclonal antibody (CP-870,893) with gemcitabine in pancreatic cancer.
    Beatty, G. L.
    Chiorean, E. G.
    Torigian, D. A.
    Teitelbaum, U. R.
    Sun, W.
    Fly, K. D.
    Huhn, R. D.
    Vonderheide, R. H.
    O'Dwyer, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers
    Ko, Andrew H.
    Chao, Joseph
    Noel, Marcus S.
    Shankaran, Veena
    Sohal, Davendra
    Crow, Mary
    Oberstein, Paul E.
    Scott, Aaron J.
    McRee, Autumn J.
    Rocha Lima, Caio Max Sao Pedro
    Fong, Lawrence
    Keenan, Bridget P.
    Soto, Maira
    Filbert, Erin L.
    Hsu, Frank J.
    Yang, Xiaodong
    CANCER RESEARCH COMMUNICATIONS, 2025, 5 (02): : 349 - 357
  • [25] Accelerated elimination of human cancer cells by a CD40 agonist antibody combined with a PD-1 antagonist in CD4-depleted mice
    Ahn, Soon-Hyun
    Choi, Joo Yeon
    Kim, Seong Dong
    Park, Sung Joon
    Kim, Hyojin
    ONCOLOGY LETTERS, 2019, 18 (06) : 5889 - 5896
  • [26] Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody
    Vonderheide, Robert H.
    Flaherty, Keith T.
    Khalil, Magi
    Stumacher, Molly S.
    Bajor, David L.
    Hutnick, Natalie A.
    Sullivan, Patricia
    Mahany, J. Joseph
    Gallagher, Maryann
    Kramer, Amy
    Green, Stephanie J.
    O'Dwyer, Peter J.
    Running, Kelli L.
    Huhn, Richard D.
    Antonia, Scott J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 876 - 883
  • [27] Adjuvant Postoperative CD40 Agonist and PD-1 Antagonist Combination Therapy in Syngeneic Tongue Cancer Mouse Model
    Ahn, Soon-Hyun
    Song, Seulki
    Kim, Sora
    ANTICANCER RESEARCH, 2020, 40 (05) : 2707 - 2713
  • [28] CD40 monoclonal antibody activation of antigen-presenting cells improves therapeutic efficacy of tumor-specific T cells
    Bergstrom, RT
    Silverman, DA
    Chambers, K
    Kim, JA
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2004, 130 (01) : 94 - 103
  • [29] YH008, a PD-1-CD40 bispecific antibody, inhibits tumor growth in vivo through PD-1-dependent activation of CD40 signaling
    Liu, Baihong
    Yang, Hao
    Hui, Li
    Yang, Benny
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
    Beckmann, Karsten
    Reitinger, Carmen
    Yan, Xianglei
    Carle, Anna
    Bluemle, Eva
    Jurkschat, Nicole
    Paulmann, Claudia
    Prassl, Sandra
    Kazandjian, Linda V.
    Lore, Karin
    Nimmerjahn, Falk
    Fischer, Stephan
    ANTIBODIES, 2024, 13 (02)
12345